NSEGeneral Updates4d ago · 26 Aug 2026, 04:27 pm
General Updates
Krishna Institute of Medical Sciences Limited · KIMS
✦ AI Summary▼ NegativeRegulatory
Krishna Institute of Medical Sciences Limited has clarified that a news report about acquiring a stake in Renova Hospitals for $52 million is false and baseless.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Limited has informed the Exchange about Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million
Attachments (1)
📄pdf
Download →
KIMS_26082026162658_Mediadisclosures.pdf
View document text
26th August, 2026
The Secretary, The Secretary,
Bombay Stock Exchange Ltd (BSE) National Stock Exchange,
Phiroze Jheejheebhoy Towers, Exchange Plaza,
Dalal Street, 5th Floor Plot No.C/1, 'G' Block
Mumbai - 400 001. Bandra - Kurla Complex
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
ISIN: INE967H01025
Dear Sir/Madam,
Sub: Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled
“ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million”
This is with reference to the news item/article titled “ChrysCapital- backed KIMS in talks to acquire stake
in Renova Hospitals for $52 Million” published in dealstreetasia.com. We would like to clarify that the
contents of the said news report/article are completely false, baseless, and factually incorrect.
As on date, the Company has neither entered into any such agreement or memorandum of understanding
(“MOU”), nor has it engaged in any discussions as alleged in the said report. The Company therefore
requests that the aforesaid clarification be taken on record and the baseless speculation and rumours
contained in the report be disregarded.
The Company further confirms that it continues to comply with all applicable disclosure requirements under
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Company will continue to make appropriate disclosures to the Stock Exchanges regarding any material
development, event or information, as and when required under the applicable laws and regulations.
Kindly take the above on your record.
Thanking You,
Yours truly
For Krishna Institute of Medical Sciences Limited
Dr. Nagajayanthi J. R.
Company Secretary and Compliance Officer